Update on Salvage Options in Relapsed/Refractory Hodgkin Lymphoma after Autotransplant
Update on Salvage Options in Relapsed/Refractory Hodgkin Lymphoma after Autotransplant
About this item
Full title
Author / Creator
Publisher
Egypt: Hindawi Publishing Corporation
Journal title
Language
English
Formats
Publication information
Publisher
Egypt: Hindawi Publishing Corporation
Subjects
More information
Scope and Contents
Contents
Despite a high clinical success, relapse in Hodgkin lymphoma occurs in 10–30% of cases and 5–10% patients are nonresponsive to initial chemotherapy. The standard management of these patients includes high-dose chemotherapy followed by autologous stem cell transplant. However, 50% of patients ultimately relapse after autotransplant which poses a big...
Alternative Titles
Full title
Update on Salvage Options in Relapsed/Refractory Hodgkin Lymphoma after Autotransplant
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4003874
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4003874
Other Identifiers
ISSN
2090-5661,2090-567X
E-ISSN
2090-567X
DOI
10.1155/2014/605691
